85 related articles for article (PubMed ID: 19134404)
1. [The detection by denaturing high performance liquid chromatography of epidermal growth factor receptor mutation in tissue and peripheral blood from patients with advanced non-small cell lung cancer].
Bai H; Zhao J; Wang SH; An TT; Wang X; Wu MN; Duan JC; Yang L; Guo QZ; Liu NH; Wang J
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Dec; 31(12):891-6. PubMed ID: 19134404
[TBL] [Abstract][Full Text] [Related]
2. [Detection of epidermal growth factor receptor mutations in non-small cell lung cancer tumor specimens from various ways by denaturing high-performance liquid chromatography].
Chen S; Chen Z; Guo A; Su J; Huang Y; Chen S; Zhang X; Yang X; Yang J; Wu Y
Zhongguo Fei Ai Za Zhi; 2010 Sep; 13(9):850-5. PubMed ID: 20840812
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancer.
Cohen V; Agulnik JS; Jarry J; Batist G; Small D; Kreisman H; Tejada NA; Miller WH; Chong G
Cancer; 2006 Dec; 107(12):2858-65. PubMed ID: 17096434
[TBL] [Abstract][Full Text] [Related]
4. Comparison of plasma and tissue samples in epidermal growth factor receptor mutation by ARMS in advanced non-small cell lung cancer.
Ma M; Shi C; Qian J; Teng J; Zhong H; Han B
Gene; 2016 Oct; 591(1):58-64. PubMed ID: 27370697
[TBL] [Abstract][Full Text] [Related]
5. Comparison of epidermal growth factor receptor mutation statuses in tissue and plasma in stage I-IV non-small cell lung cancer patients.
Zhao X; Han RB; Zhao J; Wang J; Yang F; Zhong W; Zhang L; Li LY; Wang MZ
Respiration; 2013; 85(2):119-25. PubMed ID: 22797485
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer: impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitors.
Cohen V; Agulnik JS; Ang C; Kasymjanova G; Batist G; Small D; Brandao G; Chong G; Miller WH
Cancer; 2010 Sep; 116(18):4309-17. PubMed ID: 20549828
[TBL] [Abstract][Full Text] [Related]
7. Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell-Free DNA from Patients with Advanced Non-Small Cell Lung Cancer.
Zhu G; Ye X; Dong Z; Lu YC; Sun Y; Liu Y; McCormack R; Gu Y; Liu X
J Mol Diagn; 2015 May; 17(3):265-72. PubMed ID: 25769900
[TBL] [Abstract][Full Text] [Related]
8. Highly sensitive and noninvasive detection of epidermal growth factor receptor T790M mutation in non-small cell lung cancer.
He C; Zheng L; Xu Y; Liu M; Li Y; Xu J
Clin Chim Acta; 2013 Oct; 425():119-24. PubMed ID: 23886554
[TBL] [Abstract][Full Text] [Related]
9. Comparison of EGFR signaling pathway somatic DNA mutations derived from peripheral blood and corresponding tumor tissue of patients with advanced non-small-cell lung cancer using liquidchip technology.
Zhang H; Liu D; Li S; Zheng Y; Yang X; Li X; Zhang Q; Qin N; Lu J; Ren-Heidenreich L; Yang H; Wu Y; Zhang X; Nong J; Sun Y; Zhang S
J Mol Diagn; 2013 Nov; 15(6):819-26. PubMed ID: 23988622
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three methods for detecting epidermal growth factor receptor mutations in plasma DNA samples of Chinese patients with advanced non-small cell lung cancer.
Qin L; Zhong W; Zhang L; Li LY; Wang MZ
Chin Med J (Engl); 2011 Mar; 124(6):887-91. PubMed ID: 21518597
[TBL] [Abstract][Full Text] [Related]
11. [Research Advancement on EGFR Mutation Detection of Cell-free DNA and Tumor Cell in Peripheral Blood of Patients with Non-small Cell Lung Cancer].
Zhang Y; Xu Y; Wang M
Zhongguo Fei Ai Za Zhi; 2016 Nov; 19(11):766-772. PubMed ID: 27866520
[TBL] [Abstract][Full Text] [Related]
12. Quantification and dynamic monitoring of EGFR T790M in plasma cell-free DNA by digital PCR for prognosis of EGFR-TKI treatment in advanced NSCLC.
Wang Z; Chen R; Wang S; Zhong J; Wu M; Zhao J; Duan J; Zhuo M; An T; Wang Y; Bai H; Wang J
PLoS One; 2014; 9(11):e110780. PubMed ID: 25405807
[TBL] [Abstract][Full Text] [Related]
13. Mutation profile of EGFR gene detected by denaturing high-performance liquid chromatography in Japanese lung cancer patients.
Sueoka N; Sato A; Eguchi H; Komiya K; Sakuragi T; Mitsuoka M; Satoh T; Hayashi S; Nakachi K; Sueoka E
J Cancer Res Clin Oncol; 2007 Feb; 133(2):93-102. PubMed ID: 16947044
[TBL] [Abstract][Full Text] [Related]
14. [Relationship of epidermal growth factor receptor gene mutations, clinicopathologic features and prognosis in patients with non-small cell lung cancer].
Fan MJ; Li HG; Lü ZQ; Zhang HZ; Shen XM
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):679-82. PubMed ID: 22321547
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02).
Lee JY; Qing X; Xiumin W; Yali B; Chi S; Bak SH; Lee HY; Sun JM; Lee SH; Ahn JS; Cho EK; Kim DW; Kim HR; Min YJ; Jung SH; Park K; Mao M; Ahn MJ
Oncotarget; 2016 Feb; 7(6):6984-93. PubMed ID: 26755650
[TBL] [Abstract][Full Text] [Related]
16. Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing.
Yeo CD; Kim JW; Kim KH; Ha JH; Rhee CK; Kim SJ; Kim YK; Park CK; Lee SH; Park MS; Yim HW
Lung Cancer; 2013 Aug; 81(2):207-12. PubMed ID: 23726527
[TBL] [Abstract][Full Text] [Related]
17. Can EGFR mutations in plasma or serum be predictive markers of non-small-cell lung cancer? A meta-analysis.
Wu Y; Liu H; Shi X; Song Y
Lung Cancer; 2015 Jun; 88(3):246-53. PubMed ID: 25837799
[TBL] [Abstract][Full Text] [Related]
18. [Detection of epidermal growth factor receptor mutations in non-small-cell lung carcinoma by direct sequencing and correlations with clinicopathological characteristics and sample types].
Sun MH; Yang F; Shen L; Zhang L; Chen Y; Cai X; Zhu XL; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):655-9. PubMed ID: 22321541
[TBL] [Abstract][Full Text] [Related]
19. Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer.
He C; Liu M; Zhou C; Zhang J; Ouyang M; Zhong N; Xu J
Int J Cancer; 2009 Nov; 125(10):2393-9. PubMed ID: 19530244
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor domain II, IV, and kinase domain mutations in human solid tumors.
Sihto H; Puputti M; Pulli L; Tynninen O; Koskinen W; Aaltonen LM; Tanner M; Böhling T; Visakorpi T; Bützow R; Knuuttila A; Nupponen NN; Joensuu H
J Mol Med (Berl); 2005 Dec; 83(12):976-83. PubMed ID: 16133419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
